sun pharma annual report

Sun Pharma strictly follows all Covid-19 protocols and strongly recommends that everyone wears a mask during the pandemic. Sun Pharma Yearly results, Financial Summary - The Economic Times Torrent Pharma Philippines Inc. Zao Torrent Pharma. The Yearly Results page of Sun Pharmaceutical Industries Ltd. presents the key annual result items, its comparison with the sector peers and its Annual Results for the last five years. It is mandatory to procure user consent prior to running these cookies on your website. or medium without express writtern permission of moneycontrol.com is prohibited. 27, C.S. So, lets look into Sun Pharma Inds. Some of the significant events included the acceptance of an IND (Investigational New Drug application) for the. Promoters are individuals or entities that have a significant stake in a company. This is an increase over the last, five years, when the proportion of approved NASs that were first-in-class drugs, stayed stable around 43%. Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. 1. Wrap Matrix technology is useful to develop controlled release tablets. Check out our online report for simple navigation across your devices. Board Meeting & Financial Results. Digant Haria answers, Raghuram Rajan has become a politician, doing 'shadow-boxing on someone's behalf': Ashwini Vaishnaw, Govt imposes 40% duty on onion exports to check price rise, US deports 21 Indian students in a single day over visa discrepancies, RSS-BJP placing their own people in key parts of institutional structure: Rahul Gandhi, Apple, Google and others want US government to push India to reconsider laptop, PC import curbs, Life Insurance Corporation Of India Share Price, Decoding Epfos New Guidelines How You Can Apply For Higher Pension Now, Fundamentals Of Our Company Are Very Strong Our Balance Sheet Is Healthy And Assets Robust Gautam Adani After Fpo Call Off, Valentines Day Google Celebrates February 14 The Most Romantic Day Of The Year With Animated Doodle, Google Bard Vs Chatgpt Who Will Win The Ai Chatbot Race, Adani Enterprises Fpo Fully Subscribed Group Survives Hindenburg Attack With Nii Support, Kisetsu Saison Finance India Private Limited, Excellent Escort Services Private Limited, Vihaan Direct Selling India Private Limited, Adani Group Stocks Will Averaging Out Work For Retail Investors, Indian It Companies Rode The Cloud Wave As Hyperscalers Growth Tapers How Will It Impact Them, No 5g Service Lack Of Fresh Funds Could Further Hurt Vodafone Idea Even As Airtel Jio Leap Ahead, We Want To Solve The Wazirx Binance Issue Once And For All Nischal Shetty, Falling Off The Momentum Why Retail Investors Are Losing Money After Witnessing A Long Rally, Standard Deduction Introduced In The New Tax Regime. Our website provides information about upcoming concalls and links to listen to past concalls. PDF Scaling up Specialty. Leading with Care. - Sun Pharma With travel limitations blamed for decision delays in a number of cases, this uptick could presumably have been steeper under more normal conditions.3, In addition to drug approvals, during the FY 2021-2022 USFDA also made notable regulatory decisions. and promoter group), - Per. | Standalone Financial Results. We also use third-party cookies that help us analyze and understand how you use this website. 03:31 PM, Latest investor presentations released by companies, As investors seek alpha, dvm strategies beat benchmarks by big margins, Jio Financial lists on D-St, falls 5% on expected passive fund selling, Rapid results, investor presentations and earnings calls, Equity, debt, hybrid, ETFs and fund of funds, FII, DII, retail and total open interest and changes, Explore most bullish, highest upside stocks and more, DVM screeners and other popular expert screeners, View all superstars and set superstar alerts, View Insider/SAST trades, bulk/block deals and set daily deal DESCRIPTION OF BUSINESS Ranbaxy Pharmaceuticals Canada Inc. was incorporated under the laws of the Province of Ontario on December 12, 2002. NSE: SUNPHARMA Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. Year2022 20232021 20222020 20212019 20202018 20192017 20182016 20172015 20162014 20152013 20142012 20132011 20122010 20112009 20102008 20092007 20082006 20072005 20062004 20052003 20042002 20032001 20022000 20011999 20002023 - 2024, Managing Directors Message and Management Discussion & Analysis, Business Responsibility and Sustainability Report, Self Declaration Format for Non-Resident Shareholders. What could be the listing price and trading strategy? While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. Sun Pharmaceuticals Industries (NSE:SUNPHARMA) WACC - GuruFocus - Per. Its Novel Drug Delivery Systems (NDDS) include Wrap Matrix Technology, Lipexelle technology and TearAct Technology. 12.4. Press Releases. The action you just performed triggered the security solution. www.sparc.life Disclaimer: In the same five-year period, 51% of new drugs were designated as orphan drugs.2, Orphan drugs are used to treat rare diseases, defined as less than 20,000 cases in the US. Your IP: Sun Pharmaceutical Industries Ltd. pays dividends to its shareholders on a regular basis. mcmarketstockprice->Moneycontrol/MC_Market/MC_Market_StockPrice_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_BTF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_BTF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250/MC_Market_StockPrice_Notices_300x250_ATF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_QuartResult_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_CapitalStruc_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_PriceChart_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_History_300x600_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_MTF->, Represents Equity.Intra - day transactions are permissible and normal trading is done in this category, Invest in high-rated bonds from as low as Rs. Sun Pharmaceutical Holdings USA, Inc. and Subsidiaries. Copyright 2023 Bennett, Coleman & Co. Ltd. All rights reserved. Find & Invest in bonds issued by top corporates, PSU Banks, NBFCs, and much more. Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. Click to reveal available technologies. This category only includes cookies that ensures basic functionalities and security features of the website. The investor presentations provide valuable insights into the company's operations and financial performance. Sun Pharma Advanced Research Company Limited published this content on 30 August 2022 and is solely responsible for the information contained therein. Discover the right bonds meeting your investment amount & investment horizon, Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, 15-20 High Growth Stocks primed for price jumps, 0.00 (0.00%) At Sun, we remain committed to creating long term value for our shareholders. We also use third-party cookies that help us analyze and understand how you use this website. The cautious positive outlook is driven by multiple factors, key factors supporting the outlook are: The cautious outlook has led to increase in investors selectivity for the potential investment opportunities. Our website provides the latest news about Sun Pharmaceutical Industries Ltd. from various sources such as financial news websites and social media. Liabilities include borrowings, trade payables, and other liabilities. Investors can download Sun Pharmaceutical Industries Ltd.'s investor presentations from our website and use them to make informed investment decisions. Sun Pharma - Wikipedia 100.57, dd2f77702ad.KgqUZmI7uitF-EyecqEhqDEIChXC3lLvW4oUIcV2Re8.XkLQBChyykAvgArIEZN3nGQxfG31mWGtMOxBZohHP6poUNo1BEH0XwafIw. 4.42. Sun Pharmaceutical Industries Limited | Annual Report 01-22. Sun Pharmaceutical Industries Ltd. releases its quarterly results every three months. alerts, Analyse your portfolio - Concentration analysis, Portfolio NAV and Home - Sun Pharmaceutical Industries Ltd. SECTOR:Pharmaceuticals & Drugs 37,836.15 -171.45 ( -0.45 %) ETF Funds PARTNERED BY BHARAT Bond ETF - April 2031 - Regular Plan (G) 3 Year Return: NA Sonke Pharmaceuticals (Pty) Ltd. 6. The company's balance sheet has remained strong over the years, with a healthy mix of assets and liabilities. 10,000, Unlocking opportunities in Metal and Mining, Sun Pharmaceutical Industries Stock Price, Yearly Results of Sun Pharmaceutical Industries, P/L Before Other Inc. , Int., Excpt. Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. Copyright e-Eighteen.com Ltd. All rights reserved. Important factors that could make a difference to the Company's operations include global and Indian demand supply conditions, competitors' pricing in the Company's principal markets, changes in Government regulations, tax regimes, economic developments within India and the countries within which the Company conducts businesses and other factors such as litigation and labour unrest or other difficulties. BSE:524715 Earnings Call Audio Recording. Consolidated Financial Results. Bhd., Malaysia 2. Sun Pharma Annual Report 2020 21 and Notice of 29th AGM Ranbaxy Drugs Limited 2. Sun Pharmaceutical Industries Ltd. releases an annual report every year, which provides detailed information about the company's financial performance, strategic initiatives, and future plans. Sun pharma Ravinder Sharma 17.5K views22 slides. The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Sun Pharma is the worlds fourth largest specialty generic pharmaceutical company. Jio Financial listing: Ambanis hand over $20 billion juggernaut to RIL shareholders, Biggest Adani bull GQG betting on these 6 Indian stocks too. - Per. Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. For example, District level & Mid-sized hospitals. Sun Pharmaceutical Industries Ltd.'s balance sheet provides crucial information about its financial health. Revenue Growth (TTM) Above industry Median. 173.236.176.100 Shareholding Pattern. Annual Report 2021-22. BSE: 524715, 1137.40 Copyright Sun Pharmaceutical Industries Ltd. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. of the company). Torrent Pharma (UK) Ltd. You also have the option to opt-out of these cookies. more, View news and calendar events of your holdings, Manage your watchlists. .ar{fill:#eb6135;stroke:#b24226;}.br,.dr{fill:none;}.br{stroke:#fff;}.cr{stroke:none;}, +267.43 (+0.41%) Add, track and import stocks to your On September 14, 2018, Ranbaxy Pharmaceuticals Canada Inc. changed its name to Sun Pharma Canada Inc. (the "Company"). Mumbai-based Sun Pharma posted a loss of 22.77 billion rupees ($293.6 million) for the quarter ended March 31, compared to the average 17.07 billion-rupee profit estimated by analysts in a. It has developed Elepsia XR using Wrap MatrixTM technology. These cookies do not store any personal information. Get all latest share market news, live charts, analysis, ipo, stock/share tips, indices, equity, currency and commodity market, derivatives, finance, budget, mutual fund, bond and corporate announcements more on NSEindia.com. Investors can use our pre-built screening tools to analyze Sun Pharmaceutical Industries Ltd.'s balance sheet and identify any red flags. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. Heumann Pharma GmbH & Co. Heunet Pharma GmbH. Managing Director's Message and Management Discussion & Analysis. Ranbaxy Egypt (L.L.C. Quarterly Financials, Transcripts & Earnings Call Recordings, Details of Equity Shares liable for transfer to IEPF, Details of Equity Shares transfered to IEPF, Ranbaxy Pharmaceuticals (Pty) Ltd. (Previously known as Be-Tabs Pharmaceuticals (Proprietary) Ltd, As per SEBI Circular No. At Sun, we remain committed to creating long term value for our shareholders. Dividends are a portion of the company's profits that are distributed to shareholders. We continue to focus on improving the efficiency and productivity of our R&D operations, targeted at faster new product launches and ahead of competition. Sun Pharmaceutical Industries Ltd. is a leading pharmaceutical company in India, providing a wide range of products and services to its customers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHCs). PDF CONTINUOUS - Sun Pharma Newspaper Advertisements. Ownership strength is slightly missing the benchmark. healthcare partners and the society at large. Other Pharmaceuticals. At Sun, we remain committed to creating long term value for our shareholders. Get Sun Pharmaceutical Industries latest Key Financial Ratios, Financial Statements and Sun Pharmaceutical Industries detailed profit and loss accounts. In line with this philosophy, we will continue to focus on performance and producing consistent returns. .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, Analysts take contrarian calls even as investors swoon over Sun Pharma, Buy Sun Pharmaceutical Industries; target of Rs 1265: Prabhudas Lilladher. These cookies will be stored in your browser only with your consent. All brands and trademarks are the properties of their registered owners. Sun pharma ppt - SlideShare Biotech sector soared during the pandemic, with venture capital investment and IPO volumes hitting all-time highs. watchlists, Keep track of your watchlist stocks - news, latest corporate of shares (as a % of the total sh. But opting out of some of these cookies may affect your browsing experience. Also, the USFDA updated its advice on oligonucleotides, real-world evidence (RWE), and digital health technologies, among other areas of drug development.2, The conducive development environment has led to an increase in investment from the past 2 years, especially in the year 2021.The global Research & Development (R&D) spend is expected to reach USD 254 billion at a CAGR of 4.2% from 2020 to 2026.1 While the bulk of this increase in R&D spend is expected to come from large biopharma companies, smaller players with cutting edge science are expected to have access to capital to support their R&D. Annual Reports of Subsidiary Companies. Sun Pharmaceutical Industries Directors Report, Sun Pharma Reports by The promoter holdings of Sun Pharmaceutical Industries Ltd. are relatively stable, which is a positive sign for long-term investors. Necessary cookies are absolutely essential for the website to function properly. In this article, we will analyze Sun Pharmaceutical Industries Ltd. from a stock market perspective. You also have the option to opt-out of these cookies. Equity includes share capital, reserves, and surplus. : Walkthrough for screener creation, backtesting, New superstar addition: Sunil Singhania's Abakkus. Sun Pharmaceutical Industries (Australia) Pty. Sun Pharma Advanced Research Company Ltd. - Annual reports for 2022 Who's selling? Sun Pharmaceuticals Industries's ROIC % is 15.37% (calculated using TTM income statement data). SUN PHARMACEUTICALS INDUSTRIES LIMITED supported by strong R&D capabilities of about 2,000 scientists and (SUN PHARMA) R&D investments of over 8% of annual revenues. Business Responsibility Report. Balance Sheet Date State Code04/1905031st March, 200804Capital Raised during the year (Rs in Million)Public. The share price is influenced by various factors such as the company's financial performance, global economic conditions, and market sentiment. Annual Reports. These tools can help investors make better investment decisions by providing more detailed insights into the company's financial performance and valuation. Ranbaxy Pharmaceuticals (Pty) Ltd. (Previously known as Be-Tabs Pharmaceuticals (Proprietary) Ltd. Ranbaxy Portugal Com E Desenvolv DeProd Farmaceuticos Unipessoal Lda, Sun Farmaceutica Do Brasil Ltda (Previously Known as TKS Farmaceutica Ltda), Sun Pharma Holdings (Previously Known as Nogad Holdings). The best tools reserved for subscribers to boost the performance of your investments! The Company is in the business of research and development (R&D) of pharmaceutical products to unmet medical needs in the areas of oncology, neurodegeneration and immunology. By clicking Accept, you consent to the use of ALL the cookies. Sun Pharma Advanced Research Company Limited, Sun Pharma Advanced Research : FY 2021-22. of shares (as a % of the total Share Cap. Shareholding Pattern. The stock is at a premium valuation at this point. Necessary cookies are absolutely essential for the website to function properly. Further, we extended a. from donating COVID-19 specific medicines, hand sanitisers to providing food items to, demonstrate a resilient performance while, safer and healthier world with CARE at the, Do not sell or share my personal information. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page. Ranbaxy Merger - Annual Reports - Sun Pharmaceutical Industries Ltd. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated March 16, 2023. NSE+BSE Volume, NSE Ranbaxy Malaysia Sdn. It manufactures medicines related to fields like Neurology, Diabetology, Cardiology, etc. Secretarial Compliance Report. of prom. Annual Report - Sun Pharma - Yumpu Investors can use our pre-built screening tools to analyze Sun Pharmaceutical Industries Ltd.'s share price and identify any trends or patterns. and promoter group). Sun Pharma Annual Report 2020 21 and Notice of 29th AGM - Free ebook download as Word Doc (.doc / .docx), PDF File (.pdf), Text File (.txt) or read book online for free. Ms. Rekha Sethi retired and . [4] Profit Growth (TTM) Negative Net Profit TTM Growth %. These cookies will be stored in your browser only with your consent. Sun Pharmaceutical Industries Ltd. has a large number of shareholders, including institutional investors and individual investors. Statements in this "Management Discussion and Analysis" describing the Company's objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be "forward-looking. 3. Sun Pharmaceutical Industries Ltd.'s promoters include various entities that hold a significant stake in the company. Is there value in Jio Financial after its listing today? It has also developed Xelpros, a BAK free latanoprost eye drop developed using Lipexelle technology. Investor Presentations & Transcripts. Scribd is the world's largest social reading and publishing site. Mirroring optimism and a strong trend in the economy, the domestic pharma market at the<br /> end of the year to March 04 showed a growth rate in excess of 7.3%. 59 Sun Pharma Director Report BSE: 524715 | NSE: SUNPHARMAEQ | IND: Pharma - Indian | ISIN code: INE044A01036 | SECT: Pharmaceuticals You can view full text of the Director's Report for Sun Pharmaceutical Industries Ltd. Director Report Mar2021 Mar 2022 Xelpros is commercialized by its partner in the United States. This website is using a security service to protect itself from online attacks. Ranbaxy GmbH, Germany 4. This website uses cookies to improve your experience while you navigate through the website. SUN PHARMA ANNUAL REPORT - Yumpu use of CRISPR, the first human trials using gene-editing technology. Many patient populations that previously were treated with nonselective agents are now receiving targeted agents that are tailored to the molecular and clinical features of their disease. Sun Pharma Holdings UK Limited (Formerly known as Ranbaxy Holdings (U.K.) Limited) Sun Pharma Italia SRL Sun Pharma Japan Ltd. Torrent Do Brasil Ltda. Download Annual Report in PDF format . Sun Pharmaceutical Industries Ltd. investor presentations, annual You can email the site owner to let them know you were blocked. Investors can use this information to make informed investment decisions. SUN PHARMA ANNUAL REPORT AND FINANCIAL STATEMENTS-2007-08Information required as per Part IV of Schedule VI to The Companies Act, 1956BALANCE SHEET ABSTRACT AND COMPANY'S GENERAL BUSINESS PROFILEIIIIIIIVRegistration DetailsRegistration No. Basics GmbH, Germany 3. The worldwide total prescription drug sales are forecasted to increase at a 6.4% compound annual growth rate (CAGR) from USD 1031 billion in 2021 to USD 1407 billion in 2026. Among large pharmaceutical companies, Roche had the largest R&D budget in 2021 at USD 16 billion (14.8 billion Swiss francs)4 and is expected to retain this position in 2026.1 In the United States, the total R&D spending among major pharmaceutical companies in 2020 stood at USD 72 billion, which was approximately 21.4% of total sales.5. The quarterly results are an important indicator of the company's financial health and performance. 24, Tandalja, Vadodara - 390 012. This includes generics, orphan drugs, and other prescribed drugs.1, The growth in prescription drug sales is backed by a pipeline of continuous development of Novel Active Substances (NASs). Transcripts of Sun Pharmaceutical Industries Ltd.'s concalls are available on our website. The Company assumes no responsibility to publicly update, amend, modify or revise any forward-looking statements, on the basis of any subsequent development, new information or future events or otherwise except as required by applicable law. Sun Pharma Advanced Research Company Limited Announces Resignation of Dinesh Lahoti as Company Secretary and Compliance Officer, Effective September 11, 2023, Sun Pharma Advanced Research Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2023, Latest news about Sun Pharma Advanced Research Company Limited, Sun Pharma Advanced Research Company Limited Announces That FDA Issues Complete Response Letter for Pdp-716 Nda Due to Inspection Findings At Third-Party Api Manufacturing Facility, Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023, Indian shares open higher as SVB acquisition hopes aid sentiment, Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022, Sun Pharma Advanced's Partner Launches Neonatal Seizure Drug SEZABY in US, Sun Pharma Advanced, Sun Pharma Get US FDA Nod for Neonatal Seizures Treatment Drug, Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Limited Announces U.S. FDA Approval of SEZABY (Phenobarbital Sodium Powder for Injection) for the Treatment of Neonatal Seizures, Sun Pharma Unit and SPARC Sign Licensing Deal for Neonatal Seizure Drug in US, Sun Pharma and Sun Pharma Advanced Research Company Ltd Sign Licensing Agreement, Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022, Transcript : Sun Pharma Advanced Research Company Limited - Special Call, Sun Pharma Advanced Research Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2022, Sun Pharma Advanced Research Company Widens Net Loss in Fiscal Q4, Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021, Sun Pharma Advanced Research Company Limited to Present Updated Clinical Data of Vodobatinib (SCO-088) at the 63rd ASH Annual Meeting, Sun Pharma Advanced Research Grants Licenses for Two Eye Drugs to Visiox Pharma, Sun Pharma Advanced Research Company Limited Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma, Sun Pharma Advanced Research to Acquire Exclusive Rights to Biomodifying's Antibodies as Part of New Deal, Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021, Sun Pharma Advanced Research : Shareholders Approve Appointment of CEO, Transcript : Sun Pharma Advanced Research Company Limited - Shareholder/Analyst Call, Sun Pharma Advanced Research Seeks Shareholders Nod to Raise Up to INR 18 Bn, Chart Sun Pharma Advanced Research Company Limited, Ratings for Sun Pharma Advanced Research Company Limited, Sector

Mindfulness Coach Salary, Campgrounds Along I-90 In New York, Crooked Can Workaholic, Aktiviti Night Safari Zoo Taiping, Articles S